Col­orado be­gins process to po­ten­tial­ly set pay­ment lim­it on Am­gen's arthri­tis drug En­brel

Fol­low­ing fed­er­al ef­forts like the drug price re­forms in the In­fla­tion Re­duc­tion Act, some states have al­so tak­en it in­to their own hands to curb the prices of drugs.

On Fri­day, Col­orado’s Pre­scrip­tion Drug Af­ford­abil­i­ty Board vot­ed to set an up­per pay­ment lim­it on Am­gen’s arthri­tis drug En­brel.

The vote starts a like­ly six-month process of dis­cus­sion and gath­er­ing da­ta to de­cide on what that lim­it will be. The board could al­so de­cide not to move for­ward with an up­per-lim­it pay­ment at any point in the process. The board will hold mul­ti­ple pub­lic hear­ings over the fol­low­ing months.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER